- increased circulating aspartate transaminase level / IMPC
- decreased bone mineral content / IMPC
- decreased lean body mass / IMPC
- increased circulating insulin level / IMPC
- increased total body fat amount / IMPC
- increased circulating creatine kinase level / IMPC
- decreased body length / IMPC
- increased circulating alkaline phosphatase level / IMPC
C57BL/6N-Tcf20em2(IMPC)Wtsi/WtsiKieg
Status | Available to order |
EMMA ID | EM:13550 |
International strain name | C57BL/6N-Tcf20em2(IMPC)Wtsi/WtsiKieg |
Alternative name | |
Strain type | Endonuclease-mediated |
Allele/Transgene symbol | Tcf20em2(IMPC)Wtsi |
Gene/Transgene symbol | Tcf20 |
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from CRISPR zygote microinjection. For further details see the project page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Karolinska Institutet, Stockholm, Sweden |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Non-specific syndromic intellectual disability / Orphanet_528084
IMPC phenotypes (gene matching)
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).